Hedge Fund - Madison Avenue Partners
Theravance Biopharma Inc. (TBPH)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $177,953,617 | 7.65% | 9,511,150 | $16.59 |
| 2 | 2025 - Q3 (2025-09-30) | $138,862,790 | 8.29% | 9,511,150 | $12.64 |
| 3 | 2025 - Q2 (2025-06-30) | $104,907,985 | 7% | 9,511,150 | $9.72 |
| 4 | 2025 - Q1 (2025-03-31) | $84,934,570 | 7.21% | 9,511,150 | $9.31 |
| 5 | 2024 - Q4 (2024-12-31) | $89,499,922 | 9.47% | 9,511,150 | $9.10 |
| 6 | 2024 - Q3 (2024-09-30) | $76,659,869 | 7.1% | 9,511,150 | $8.66 |
| 7 | 2024 - Q2 (2024-06-30) | $72,176,248 | 9.11% | 8,511,350 | $9.03 |
| 8 | 2024 - Q1 (2024-03-31) | $62,899,667 | 10.14% | 7,012,226 | $9.27 |
| 9 | 2023 - Q4 (2023-12-31) | $78,817,420 | 11.12% | 7,012,226 | $10.06 |
| 10 | 2023 - Q3 (2023-09-30) | $60,515,510 | 8.58% | 7,012,226 | $9.65 |
| 11 | 2023 - Q2 (2023-06-30) | $72,576,538 | 15.83% | 7,012,226 | $11.04 |
| 12 | 2023 - Q1 (2023-03-31) | $76,082,653 | 16.36% | 7,012,226 | $10.57 |
| 13 | 2022 - Q4 (2022-12-31) | $78,677,176 | 13.93% | 7,012,226 | $10.51 |
| 14 | 2022 - Q3 (2022-09-30) | $71,104,000 | 15.25% | 7,012,226 | $9.37 |
| 15 | 2022 - Q2 (2022-06-30) | $65,862,000 | 13.47% | 7,269,584 | $9.21 |
| 16 | 2022 - Q1 (2022-03-31) | $69,497,000 | 12.97% | 7,269,584 | $9.80 |
| 17 | 2021 - Q4 (2021-12-31) | $73,461,000 | 15.9% | 6,648,025 | $8.72 |
| 18 | 2021 - Q3 (2021-09-30) | $36,478,000 | 8.08% | 4,929,423 | $11.19 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center